Kai Liu

Targeting the PD-L1/DNMT1 axis in acquired resistance to sorafenib in human hepatocellular carcinoma

Jianhua Liu, Yahui Liu, Lingyu Meng et al. · Oncology Reports · 2017 · 92 citations · Full text

Medicine, Molecular Biology, Oncology +17

Exosomal miR-9-3p suppresses HBGF-5 expression and is a functional biomarker in hepatocellular carcinoma

Jie Tang, Yun Li, Kai Liu et al. · Minerva Medica · 2017 · 81 citations

Life Sciences, Molecular Biology, Oncology +15

Diindolylmethane Alters Gene Expression in Human Keratinocytes In Vitro

Timothy H. Carter, Kai Liu, W Ralph et al. · Journal of Nutrition · 2002 · 67 citations

Medicine, Dermatology, Molecular Genetics +13

S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway

Zongliang Lu, Rui Zhou, Ya Kong et al. · Current Cancer Drug Targets · 2016 · 60 citations

Medicine, Oncology, Pharmacology +13

Association between triglyceride glucose index-related indices with gallstone disease among US adults

Chang Fu, Xiaocong Li, Yongxin Wang et al. · Lipids in Health and Disease · 2024 · 40 citations · Full text

Medicine, Endocrinology, Diabetology +12